National Psoriasis Foundation Email for Ilumya: “Get your plaque psoriasis questions answered! – Partner Message”

Brand: Ilumya (tildrakizumab-asmn), Injection
Parent Company: Sun Pharma
Drug Type: Prescription
Drug Category: Dermatology
Campaign: now-approved, Now Available
Targeting: Patients, Caregivers
Patient Website: https://www.ilumya.com/
HCP Website: https://www.ilumyapro.com